{
  "docId": "019de071-805e-75da-a9c3-e9573cb6e94f",
  "docSlug": "f179c2894ff7ef65a3c6d24dd4bec442",
  "documentTitle": "Exscientia | IPO Presentation Deck | 60 slides",
  "authorId": "exscientia",
  "authorName": "Exscientia",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7893755,
  "pageNumber": 32,
  "pageCount": 60,
  "prevPage": 31,
  "nextPage": 33,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 30,
  "notes": "The slide uses a small multiples approach to show individual patient responses across three different experiments (EXP403, EXP617, EXP665) and three time points (24h, 48h, 72h).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-805e-75da-a9c3-e9573cb6e94f/32",
  "deckHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f",
  "deckJsonHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f.json",
  "deckAnchorHref": "/decks/019de071-805e-75da-a9c3-e9573cb6e94f#slide-32",
  "components": [
    {
      "bbox": {
        "h": 0.12,
        "w": 0.7,
        "x": 0.15,
        "y": 0.82
      },
      "kind": "callout",
      "text": "Group II (n=4) require higher concentrations of EXS617 than Group I (n=6) for effect. Understanding why will guide patient selection and is the focus of ongoing studies",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "99181483-a530-4fdc-9fe7-1d50cbbfc039",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.15,
        "x": 0.8,
        "y": 0.15
      },
      "kind": "chart",
      "text": "Summary dot plots for Group I vs Group II at 24h, 48h, and 72h",
      "attrs": null,
      "subkind": "dot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "34deca7a-3ba8-48e5-9117-c94ef3581b0e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.75,
        "x": 0.04,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Dose-response curves for individual patient samples grouped by sensitivity",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ce204b5a-cc32-4195-a5de-88f9751311e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.5,
        "x": 0.03,
        "y": 0.12
      },
      "kind": "title",
      "text": "EXS617: ovarian cancer patient samples stratify into two groups",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ef39d4a-e239-4091-ba6e-397abb5b8c1d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "CDK7i – defining patient selection during drug design",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d7a27c35-c5eb-4afc-9595-bfa7e7bf7450",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "ac87ad6b-0694-4433-aace-c0ecfcac8aa7",
      "evidence": "chart/line: Dose-response curves for individual patient samples grouped by sensitivity",
      "confidence": 0.6
    }
  ],
  "frameworks": [
    {
      "name": "small-multiples",
      "slug": null,
      "matchId": "b42a223d-9a28-4966-b9c0-e8685cd40d2d",
      "evidence": "The slide uses a grid of identical charts to compare individual patient responses.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 60,
      "from": 4,
      "beatId": "5dda98c6-c560-4b21-aa1c-95b617a27a20",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The deck presents a comprehensive solution throughout pages 4-60.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    },
    {
      "to": 32,
      "from": 28,
      "beatId": "364bb9c2-365f-49cf-9e48-6bd24128bcdc",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Competition",
      "beatSlug": "sequoia-pitch-competition",
      "evidence": "The deck discusses competition on pages 28-32.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 60,
      "from": 4,
      "name": "Golden Circle",
      "slug": "11-golden-circle",
      "bestFor": "Visionary leadership, brand positioning, mission statements",
      "matchId": "3b6b60bf-18b7-4458-bffa-eba1b1ca0583",
      "evidence": "The deck presents a comprehensive loop on the golden circle of problem-solution-benefit.",
      "position": 1,
      "objective": "Explain how Exscientia's AI-driven platform can solve the problem of inefficient drug discovery.",
      "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
      "confidence": 0.7,
      "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}